Titlebook: Chronic Lymphocytic Leukemia; Michael Hallek,Barbara Eichhorst,Daniel Catovsky Book 2019 Springer Nature Switzerland AG 2019 Chronic Lymph

尤指植物

書目名稱Chronic Lymphocytic Leukemia影響因子(影響力)




書目名稱Chronic Lymphocytic Leukemia影響因子(影響力)學(xué)科排名




書目名稱Chronic Lymphocytic Leukemia網(wǎng)絡(luò)公開度




書目名稱Chronic Lymphocytic Leukemia網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Chronic Lymphocytic Leukemia被引頻次




書目名稱Chronic Lymphocytic Leukemia被引頻次學(xué)科排名




書目名稱Chronic Lymphocytic Leukemia年度引用




書目名稱Chronic Lymphocytic Leukemia年度引用學(xué)科排名




書目名稱Chronic Lymphocytic Leukemia讀者反饋




書目名稱Chronic Lymphocytic Leukemia讀者反饋學(xué)科排名

巨碩

finite

The Clinical Presentation of CLLedominantly a disease of the elderly with a preponderance of male patients. New evidence suggests that there are variations in gender incidence according to the clinical status of patients, with a higher male:female ratio in the groups with worse prognosis..Full blood counts and a physical examinati

儀式

鉤針織物

Guidelines for Diagnosis, Indications for Treatment, Response Assessment, and Supportive Management road acceptance by physicians and investigators caring for patients with CLL. It is not the aim of the iwCLL guidelines to provide treatment recommendations, but definitions for the initial assessment, indication for treatment, and response assessment of CLL. Recent advances including the discovery

gruelling

Initial Therapy of Chronic Lymphocytic Leukemiaients without very high-risk genomic alterations first-line treatment with chemoimmunotherapy is a well-examined and established standard of care. FCR is the preferred treatment in physically fit patients with mild or no comorbidities. Depending on the burden of comorbidities, less intense chemoimmu

gruelling

Employee

上下倒置

Autoimmune Cytopenia in Chronic Lymphocytic Leukemiauses, patients with CLL presenting cytopenia require a careful evaluation and an individualized management. The association of CLL with cytopenias of immune origin is based on experts’ consensus, and its impact on patients’ outcome remains controversial. It is widely accepted that treatment should b

青少年

Richter Syndromeare recognized, namely the diffuse large B-cell lymphoma (DLBCL) variant and the rare Hodgkin lymphoma (HL) variant. Histologic documentation is mandatory to diagnose RS. In the presence of clinical features suspicious of RS, diagnosis of transformation and choice of the site of biopsy may take adva